The presence of multiple growth stimuli at the sites of vascular injury following angioplasty suggests that therapies targeted toward common growth pathways will be more effective than therapies that inhibit only a single growth factor. We tested this hypothesis using amiloride and ethyl isopropyl amiloride (EIPA), [RNHE(-)]. Studies with these cells suggested that the inhibitory effects of EIPA and amiloride were mediated only in part via Na+-H+ exchange because (1) RNHE(-) cells grew well at pH 6.8 to 7.5 in bicarbonate-containing medium, and (2) there was no difference in migration in response to platelet-derived growth factor in the RNHE(-) cells. In summary, these data indicate that amiloride and EIPA inhibit neointimal formation in the rat carotid after injury. However, the mechanism of inhibition is likely to involve cellular events other than Na+-H+ exchange, such as an effect on tyrosine kinases. (Circulation Research 1993;73:269-275) 
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The presence of multiple growth stimuli at the sites of vascular injury following angioplasty suggests that therapies targeted toward common growth pathways will be more effective than therapies that inhibit only a single growth factor. We tested this hypothesis using amiloride and ethyl isopropyl amiloride (EIPA), which are inhibitors of the Na+-H+ exchanger, whose activity is required in many cells for proliferation and migration. In the rat carotid injury model, EIPA (100 ,ug/h for 15 days) significantly decreased intimal area and the ratio of intimal to medial area, whereas amiloride (25 jag/h) showed an inhibitory trend that was similar to that observed for captopril (80 mg/kg per day) and heparin (25 U/h). EIPA and amiloride inhibited rat vascular smooth muscle cell DNA synthesis, with IC5* values of 8.8 and 82.2 ,uM, respectively. Using platelet-derived growth factor as a chemoattractant, EIPA caused a concentrationdependent inhibition of migration (IC50, =60 pM). Because amiloride and EIPA have nonspecific effects on cellular function (especially inhibition of tyrosine kinases), we sought to characterize the specific role of the Na+-H+ exchanger in vascular smooth muscle cell proliferation and migration. We generated a Na+-H+ exchanger-deficient mutant cell line [RNHE(-)]. Studies with these cells suggested that the inhibitory effects of EIPA and amiloride were mediated only in part via Na+-H+ exchange because (1) RNHE(-) cells grew well at pH 6.8 to 7.5 in bicarbonate-containing medium, and (2) there was no difference in migration in response to platelet-derived growth factor in the RNHE(-) cells. In summary, these data indicate that amiloride and EIPA inhibit neointimal formation in the rat carotid after injury. However, the mechanism of inhibition is likely to involve cellular events other than Na+-H+ exchange, such as an effect on The failure of therapy targeted to individual growth factors suggested that an approach to limiting VSMC growth and migration based on a mechanism that was common to all growth factors might be successful. The amiloride-sensitive Na+-H+ exchanger (specifically the NHE-1 isoform) is a ubiquitous membrane transport protein that exchanges intracellular H' for extracellular Na+ in its normal transport mode. The Na+-H+ exchanger is activated by all growth factors as one of the earliest events associated with entrance of cells into the cell cycle.8 Amiloride and its derivatives are potent inhibitors of Na+-H+ exchange.9 These compounds inhibit cell growth in a concentration-dependent fashion that correlates with their potency as inhibitors of Na+-H+ exchange. tive "Na' influx and amiloride-sensitive pH recovery as described below. EIPA-sensitive Na+-H+ exchange was decreased =80% after one round of selection, and additional rounds of selection yielded cells completely devoid of Na+-H+ exchange activity.
Cell Migration
Cell migration was performed as previously described. 19 In brief, the lower chamber of a 48-well microchemotaxis chamber was filled with DME supplemented with 0.2% bovine serum albumin (BSA) and 10 ng/mL platelet-derived growth factor (PDGF) B chain plus or minus drug. The chamber was sealed with a collagen-coated filter (pore diameter, 8 ,um). The upper chamber containing bovine VSMCs (10' cells in 50 ,tL, passages 5 to 7) in DME supplemented with 0.2% BSA plus or minus drug was then placed on the assembly.
Migration was performed at 370C in an air-CO2 incubator for 4 hours. Migrated cells were fixed and stained with Diff Quik and then quantitated using a scanning densitometer (CS-9000, Shimadze Co, Japan).
Measurement of Na+-H+ Exchange Activity
The activity of Na+-H+ exchange was measured by 22Na' influx and by pH recovery from an acid load as previously described. 16 For both assays, cells were maintained in DME supplemented with 0.4% serum until assayed. For 22Na' influx, the dishes were washed with an HCO,-and Na+-free balanced salt solution (Na+-free buffer) at 30°C containing (mM) choline chloride, 130; KCl, 5; CaCl2, 2; MgCl2, 1; and Tris-HEPES, 20 (pH 6.9). Cells were preincubated in this solution containing 10 mM glucose and 1 mg/mL BSA for 30 minutes with 1 mM ouabain; 0.1 mM bumetanide was added for the final 5 minutes. To initiate influx, the medium was replaced by a HCO, -free influx medium of the same composition except for the addition of 1 ,uCi/mL 22Na+, 1 mM ouabain, 0.1 mM bumetanide, and 130 mM NaCl (plus choline chloride), with or without 60 ,uM EIPA (pH 7.4). The concentration of EIPA chosen was based on previous studies indicating a K, in VSMCs of 22 ,M for amiloride.16 The influx was terminated by rapid aspiration followed by six washes of ice-cold 100 mM MgCl2. Incorporated 22Na+ was measured in a gamma counter and corrected for cell protein and counter efficiency. The fluorescent pH indicator 2',7'-bis(carboxyethyl-5(6)-fluorescein) (BCECF) was used to measure pHi as previously described. 16 Briefly, cells were loaded for 30 minutes in a 37°C water bath with 3 ,uM BCECF AM in Hanks' solution. Fluorescent measurements were performed in an SLM DX-1000 spectrofluorometer equipped with a beam splitter, two excitation monochromators, and a dual chopping mechanism to allow rapid alternating excitation of BCECF at 500 and 438 nm. The emission ratio of the fluorescence signals at 530 nm was used to determine pHi after calibration of the pH, relative to fluorescence intensity using 10 ,.tM nigericin in 135 mM KCl, 10 (5 x104 cells in 100 ,L) were plated in 96-well plates in 10% fetal calf serum/DME. The next day the medium was removed, cells were rinsed with 5% platelet-depleted serum (PDS/DME), and grown in 5% PDS/DME for 24 hours. On day 3, fresh 5% PDS/DME was added containing 10 Initially, a clonal VSMC cell line [RNHE(+)] was prepared. These cells were then mutagenized and selected by acid suicide to generate the Na+-H+ exchange-deficient mutant cell line RNHE(-), as described in "Materials and Methods." We confirmed the lack of Na+-H+ exchange activity in RNHE(-) cells by pH recovery and Na+ influx: RNHE(-) cells failed to recover from an acid load in the absence of bicarbonate (Fig 5) and also showed no significant EIPA-sensitive 22Na+ influx (Fig 6) .
To study the role of the Na+-H+ exchanger in cell proliferation, we compared the ability of RNHE(+) and RNHE(-) cells to grow in the presence or absence of bicarbonate. Both cell types grew well in DME containing bicarbonate (pH 6.8 to 7.5) (Fig 7) . When placed in a medium lacking bicarbonate (L-15), there was no significant change in growth at pH 7.5. In contrast, at pH 6.8 cell growth was inhibited to a much greater extent in RNHE (-) (Fig 8) . These (Fig 9) . Although PDGF stimulated a concentration-dependent increase in cell migration (data not shown), this did not differ significantly between RNHE(+) and RNHE(-) cells (Fig 9 shows results for 10 ng/mL PDGF). The Na+-H+ exchanger therefore has no apparent role in PDGF-stimulated migration of VSMCs. EIPA inhibited RNHE(-) migration with a Ki of~60 ,uM (Fig 3, open symbols) , which was not significantly different from that found in RNHE(+) cells or bovine VSMCs (Fig 3, solid symbols; Discussion Restenosis remains the major complication following coronary angioplasty. Despite almost a decade of investigation into this problem, no completely effective therapy has been found. 6, 7 VSMCs, the target of intensive research, respond to a wide range of growth factors. Thus, therapies that inhibit intracellular events common to many growth factors appear promising. For this reason, we chose to study the role of the Na+-H+ exchanger, specifically investigating two of its inhibitors, EIPA and amiloride. Although EIPA was clearly effective in inhibiting restenosis (and amiloride showed an inhibitory trend), our experiments suggest that amiloride and EIPA exert their effects independent of the Na+-H+ exchanger.
The present work produced two useful findings: (1) EIPA significantly inhibits neointimal formation in the rat carotid after injury. EIPA and, to a lesser degree, amiloride were as effective as captopril and heparin at nontoxic doses. (2) Knowledge of the fact that certain drugs inhibit neointimal formation is not enough; the precise mechanisms by which this occurs need to be studied and defined. The combined data of our tissue culture and in vivo studies yield an interesting result: the inhibition of neointimal formation by amiloride and EIPA is apparently independent of the effects of these drugs on the Na+-H+ exchanger.
In seeking to determine the mechanism by which EIPA and amiloride inhibit neointimal formation in vivo, we carried out several in vitro experiments. The results suggest that EIPA and amiloride decrease neointimal formation via inhibition of both VSMC proliferation and migration. Inhibition of VSMC proliferation appears to be largely due to inhibition of the Na+-H+ exchanger. Data to support a predominant role for the Na+-H+ exchanger include the following: (1) DNA synthesis was reduced by these agents in a concentration-dependent manner that paralleled their potency as Na+-H+ exchange inhibitors. (2) RNHE(-) cells failed to grow in the absence of bicarbonate at pH <6.8. (3) VSMC growth was inhibited in a concentration-dependent manner by amiloride-like drugs.11 (4) Inhibition of Na+-H+ exchange prevents induction of genes required for DNA synthesis and cell cycle progression.12 However, there is also evidence that EIPA and amiloride inhibit proliferation by mechanisms other than blockade of the Na+-H+ exchanger. Specifically, the requirement for Na+-H+ exchange is weakened by the fact that RNHE(-) cells grew as well as the RNHE(+) cells in the presence of bicarbonate and in the absence of bicarbonate at pH 7.5. Although it is possible that pH might be <7.0 in an injured vessel, it seems likely that C02/bicarbonate would always be present. The most likely alternative mechanism of action for EIPA and amiloride would be inhibition of cell protein kinases. Recent data15'21 suggest that amiloride and EIPA inhibit tyrosine kinases, which are critical mediators of many growth signals. In summary, VSMC growth inhibition by EIPA and amiloride appears to be mediated by more than one mechanism, including inhibition of Na+-H+ exchange and possibly protein tyrosine kinases.
Inhibition of VSMC migration by amiloride and EIPA appears to be largely independent of the Na+-H+ exchanger. We found that RNHE(-) cells exhibited no Inhibition of neointimal formation in vivo by EIPA and amiloride may also be due to inhibition of autocrine growth mechanisms. For example, these agents probably decrease VSMC protein synthesis.14 This effect may be particularly important in vivo, since autocrine growth mechanisms, such as production of angiotensin II, fibroblast growth factor, and PDGF by VSMCs, may contribute importantly to VSMC growth and neointimal formation.6,7,23 EIPA and amiloride, by decreasing protein synthesis, would block these autocrine growth pathways. Further research will be needed to examine these possibilities.
Our hypothesis in doing the present work was based on the idea that inhibiting cell signaling events common to all growth factors would be an effective therapy against restenosis. We targeted the Na+-H+ exchanger using the specific inhibitors EIPA and amiloride. Although they were effective in inhibiting cell migration and proliferation, the inhibitors appeared to work independent of the Na+-H+ exchanger. Given these findings, we see two possible directions for future studies: (1) to define the cellular substrates of EIPA and amiloride action, especially the role of kinases, and (2) to determine whether there are VSMC-specific targets for drugs of the amiloride class, especially autocrine growth pathways.
